drugset / Trial / NCT01374802

Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers

NCT01374802

Phase 1 Completed 14 enrolled Boehringer Ingelheim
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The objective of the current study is to investigate the effect of multiple oral daily doses of BI 201335 on the steady-state pharmacokinetics of darunavir co-administered with ritonavir.

Timeline

Start
2011-06
Primary completion
2011-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Darunavir Small molecule 800 mg Oral
Subject Faldaprevir Small molecule 240 mg Oral
Background Ritonavir Other / unclassified 100 mg Oral